Validity and reliability of the Hungarian version of the Pain Self-efficacy Questionnaire among women with endometriosis and chronic pelvic pain

Zsófia Kovács-Szabó, Alexandra Makai, Pongrác Ács, Márta Hock
In: Research Square · 2024 · doi:10.21203/rs.3.rs-4060366/v1 · W4393231698
preprint OA: green CC0
📄 Open PDF View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This study assessed the reliability and validity of the Hungarian version of the Pain Self-Efficacy Questionnaire in women with chronic pelvic pain, finding it to be a reliable and valid measurement tool.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-09 ⓘ

This study aimed to translate and cross-culturally adapt the Pain Self-Efficacy Questionnaire (PSEQ) into Hungarian (PSEQ-HU) and evaluate its reliability and validity among Hungarian women aged 18–50 with endometriosis-related chronic pelvic pain, recruited via endometriosis support groups in an online, cross-sectional survey. Reliability was assessed using internal consistency and test-retest measures (n=262), while construct validity used confirmatory factor analysis and convergent/discriminant validity used correlations with SF-36, pain catastrophizing (PCS), perceived stress (PSS), and numeric pain rating scale groupings. The PSEQ-HU showed very high internal consistency (Cronbach’s α=0.966) and adequate test-retest reliability (ICC=0.939, 95% CI 0.884–0.968), with significant correlations between pain-related self-efficacy and quality of life, perceived stress, and pain catastrophizing; however, the paper notes it is a preprint and thus not peer reviewed. This paper is centrally about endometriosis — specifically, it validates the Hungarian Pain Self-Efficacy Questionnaire in women with endometriosis-related pelvic pain and chronic pelvic pain.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Our study aimed to perform Hungarian cross-cultural adaptation and assess the reliability and validity of the Pain Self-Efficacy Questionnaire (PSEQ) among women with chronic pelvic pain. The current study was conducted in Hungary among women aged 18–50 (34,39 ± 6,68 years). Besides PSEQ, the 36 Item Short-Form Health Survey (SF36), Visual Analog Scale (VAS), and Perceived Stress Scale (PSS) were used. We examined the reliability of the PSEQ-HU by applying internal consistency and test-retest evaluations. For construct validity of the PSEQ-HU we used confirmatory factor analysis (CFA) and for convergent validity Spearman rank correlation analysis was performed to assess the correlations between PSEQ-HU and SF-36, PCS, PSS and NRS. For discriminant validity two groups were created based on the NRS (0–4, 5–10). The results were analyzed via IBM SPSS version 28.0 software with a significance level of p < 0.05. 262 women took part in the study. Cronbach’s α was 0.966, the intraclass correlation coefficient values showed adequate reliability (ICC = 0.939. 95% CI 0.884–0.968) for the PSEQ-HU. Spearman correlation analysis showed significant correlations between pain-related self-efficacy and health-related quality of life, perceived stress levels and pain catastrophizing. We concluded that PSEQ is a reliable and valid measurement among Hungarian women endometriosis-related pelvic pain. ClinicalTrials.gov registration: https://register.clinicaltrials.gov/prs/app/action/LoginUser?ts=1&cx=-jg9qo4 Unique protocol ID: 9534-PTE2023 NCT05863663

My notes (saved in your browser only)

Outcome instruments

VAS-pain NRS-pain

Condition tags

endometriosischronic_pelvic_pain

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (50)

Source provenance

europepmc
last seen: 2026-06-19T06:31:37.701799+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK